Biologic relevance of mammalian bombesin-like peptides and their receptors in human malignancies

Current Opinion in Endocrinology and Diabetes

Volumn 10, Issue 1, 2003, Pages 60-71

  Qu, Xiangping ^a   Xiao, Dongmei ^a   Weber, H Christian ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN DERIVATIVE; BOMBESIN LIKE PEPTIDE; BOMBESIN RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

AUTOCRINE EFFECT; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HORMONE RELEASE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PARACRINE SIGNALING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SATIETY; SMOOTH MUSCLE CONTRACTION; THERMOREGULATION;

EID: 25444521559     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200302000-00010     Document Type: Review

References (177)

1. Kroog GS, Jensen RT, Battey JF: Mammalian bombesin receptors. Med Res Rev 1995, 15:389-417.
2. Spindel ER, Giladi E, Segerson TP, et al.: Bombesin-like peptides: of ligands and receptors. Recent Prog Horm Res 1993, 48:365-391.
3. Xiao D, Wang J, Hampton LL, et al.: The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene 2001, 264:95-103.
4. Ishikawa-Brush Y, Powell JF, Bolton P, et al.: Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3′ to the SDC2 gene. Hum Mol Genet 1997, 6:1241-1250.
5. Jensen JA, Carroll RE, Benya RV: The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 2001, 22:689-699.
6. Ohki-Hamazaki H, Watase K, Yamamoto K, et al.: Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997, 390:165-169.
7. Weber D, Berger C, Heinrich T, et al.: Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3. J Pept Sci 2002, 8:461-475. This study investigates further the structural requirements of a previously identified synthetic peptide selectively binding to the human BRS-3. A tripeptide with selective agonist properties on the human BRS-3 is identified.
8. Liu J, Lao ZJ, Zhang J, et al.: Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). Biochemistry 2002, 41:8954-8960. This report on the molecular cloning and pharmacology of the rat BRS-3 suggests that ligand binding of a synthetic BRS-3 peptide is species-specific and may involve extracellular domain 3.
9. Pradhan TK, Katsuno T, Taylor JE, et al.: Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharmacol 1998, 343:275-287.
10. Ryan RR, Weber HC, Hou W, et al.: Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3. J Biol Chem 1998, 273:13613-13624.
11. Mantey SA, Weber HC, Sainz E, et al.: Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem 1997, 272:26062-26071.
12. Anastasi A, Erspamer V, Bucci M: Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 1971, 27:166-167.
13. McDonald TJ, Jornvall H, Nilsson G, et al.: Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979, 90:227-233.
14. Naylor SL, Sakaguchi AY, Spindel E, et al.: Human gastrin-releasing peptide gene is located on chromosome 18. Somat Cell Mol Genet 1987, 13:87-91.
15. Lebacq-Verheyden AM, Bertness V, Kirsch I, et al.: Human gastrin-releasing peptide gene maps to chromosome band 18q21. Somat Cell Mol Genet 1987, 13:81-86.
16. Spindel ER, Chin WW, Price J, et al.: Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A 1984, 81:5699-5703.
17. Sausville EA, Lebacq-Verheyden AM, Spindel ER, et al.: Expression of the gastrin-releasing peptide gene in human small cell lung cancer: evidence for alternative processing resulting in three distinct mRNAs. J Biol Chem 1986, 261:2451-2457.
18. Walter P, Ibrahimi I, Blobel G: Translocation of proteins across the endoplasmic reticulum, I: signal recognition protein (SRP) binds to in-vitro-assembled polysomes synthesizing secretory protein. J Cell Biol 1981, 91:545-550.
19. Scheele G, Jacoby R: Proteolytic processing of presecretory proteins is required for development of biologic activities in pancreatic exocrine proteins. J Biol Chem 1983, 258:2005-2009.
20. Bradbury AF, Finnie MD, Smyth DG: Mechanism of C-terminal amide formation by pituitary enzymes. Nature 1982, 298:686-688.
21. Eipper BA, Myers AC, Mains RE: Peptidyl-glycine alpha-amidation activity in tissues and serum of the adult rat. Endocrinology 1985, 116:2497-2504.
22. Moody TW, Pert CB, Rivier J, et al.: Bomebesin: specific binding to rat brain membranes. Proc Natl Acad Sci U S A 1978, 75:5372-5376.
23. Orloff MS, Reeve JR Jr, Ben-Avram CM, et al.: Isolation and sequence analysis of human bombesin-like peptides. Peptides 1984, 5:865-870.
24. Bunnett NW, Orloff MS, Turner AJ: Catabolism of substance P in the stomach wall of the rat. Life Sci 1985, 37:599-606.
25. Bishop JF, Moody TW, O'Donohue TL: Peptide transmitters of primary sensory neurons: similar actions of tachykinins and bombesin-like peptides. Peptides 1986, 7:835-842.
26. Dockray GJ, Vaillant C, Walsh JH: The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract. Neuroscience 1979, 4:1561-1568.
27. Track NS, Cutz E: Bombesin-like immunoreactivity in developing human lung. Life Sci 1982, 30:1553-1556.
28. Price J, Penman E, Wass JA, et al.: Bombesin-like immunoreactivity in human gastrointestinal tract. Regul Pept 1984, 9:1-10.
29. Korman LY, Carney DN, Citron ML, et al.: Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung. Cancer Res 1986, 46:1214-1218.
30. Kee KA, Finan TM, Korman LY, et al.: Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cells. Peptides 1988, 9:257-261.
31. Taylor JE, Moreau JP, Baptiste L, et al.: Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Peptides 1991, 12:839-843.
32. Moody TW, Zia F, Venugopal R, et al.: Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells. Peptides 1994, 15:281-285.
33. Yashi M, Muraishi O, Kobayashi Y1 et al.: Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients. Prostate 2002, 51:84-97. This clinical study showed that the serum proGRP levels were positively correlated with the prostate-specific antigen values in patients with untreated prostate cancer. ProGRP values increased transiently when the cancer progressed to an androgen-independent state. It was suggested that GRP may be a growth factor potentially upregulated by androgen.
34. Minamino N, Kangawa K, Matsuo H: Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 1983, 114:541-548.
35. Minamino N, Kangawa K, Matsuo H: Neuromedin B is a major bombesin-like peptide in rat brain: regional distribution of neuromedin B and neuromedin C in rat brain, pituitary and spinal cord. Biochem Biophys Res Commun 1984, 124:925-932.
36. Namba M, Ghatei MA, Bishop AE, et al.: Presence of neuromedin B-like immunoreactivity in the brain and gut of rat and guinea-pig. Peptides 1985, 6:257-263.
37. Sakamoto A, Kitamura K, Haraguchi Y, et al.: Immunoreactive neuromedin B and neuromedin C: distribution and molecular heterogeneity in rat and human tissue extracts. Am J Gastroenterol 1987, 82:1035-1041.
38. Steel JH, Van Noorden S, Ballesta J, et al.: Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. Endocrinology 1988, 122:270-282.
39. Krane IM, Naylor SL, Helin-Davis D, et al.: Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B: chromosomal localization and comparison to cDNAs encoding its amphibian homolog ranatensin. J Biol Chem 1988, 263:13317-13323.
40. Moody TW, Staley J, Zia F, et al.: Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. J Pharmacol Exp Ther 1992, 263:311-317.
41. Siegfried JM, Krishnamachary N, Gaither Davis A, et al.: Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pulm Pharmacol Ther 1999, 12:291-302.
42. Cardona C, Rabbitts PH, Spindel ER, et al.: Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines. Cancer Res 1991, 51:5205-5211.
43. Bostwick DG, Bensch KG: Gastrin releasing peptide in human neuroendocrine tumors. J Pathol 1985, 147:237-244.
44. Sunday ME, Choi N, Spindel ER, et al.: Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas. Hum Pathol 1991, 22:1030-1039.
45. Verbeeck MA, Elands JP, de Leij LF, et al.: Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiology 1992, 60:136-142.
46. lnase N, Horita K, Tanaka M, et al.: Use of gastrin-releasing peptide promoter for specific expression of thymidine kinase gene in small-cell lung carcinoma cells. Int J Cancer 2000, 85:716-719.
47. Reubi JC, Wenger S, Schmuckli-Maurer J, et al.: Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Clin Cancer Res 2002, 8:1139-1146. A large number of various human cancer tissues was investigated for the expression of all bombesin receptor subtypes using in vitro radio-ligand binding assays with a synthetic universal peptide ligand.
48. Aguayo SM, Miller Y, Boose D, et al.: Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells. Cell Growth Differ 1996, 7:563-572.
49. Moody TW, Zia F, Venugopal R, et al.: GRP receptors are present in non small cell lung cancer cells. J Cell Biochem Suppl 1996, 24:247-256.
50. Cardona C, Bleehen NM, Reeve JG: Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line. Biochem J 1992, 281:115-120.
51. Hamid QA, Corrin B, Dewar A, et al.: Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung. J Pathol 1990, 161:145-151.
52. DeMichele MA, Davis AL, Hunt JD, et al.: Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994, 11:66-74.
53. Pagani A, Papotti M, Sanfilippo B, et al.: Expression of the gastrin-releasing peptide gene in carcinomas of the breast. Int J Cancer 1991, 47:371-375.
54. Vangsted AJ, Andersen EV, Nedergaard L, et al.: Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer. Breast Cancer Res Treat 1991, 19:119-128.
55. Reubi C, Gugger M, Waser B: Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med Mol Imaging 2002, 29:855-862.
56. Gugger M, Reubi JC: Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 1999, 155:2067-2076.
57. Giacchetti S, Gauville C, de Cremoux P, et al.: Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J Cancer 1990, 46:293-298.
58. Bajo AM, Schally AV, Krupa M, et al.: Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes. Proc Natl Acad Sci U S A 2002, 99:3836-3841.
59. Suzuki M, Yamaguchi K, Abe K, et al.: Detection of gastrin-releasing peptide mRNA in small cell lung carcinomas and medullary thyroid carcinomas using synthetic oligodeoxyribonucleotide probes. Jpn J Clin Oncol 1987, 17:157-163.
60. Modigliani E, Casanova S, Chayvialle JA, et al.: Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma. J Clin Endocrinol Metab 1990, 71:831-835.
61. Pfragner R, Wirnsberger GH, Ingolic E, et al.: Medullary thyroid carcinomas in cell culture-models for future therapies. Wien Klin Wochenschr 2002, 114:279-283.
62. Carroll RE, Carroll R, Benya RV: Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas. Peptides 1999, 20:229-237.
63. Bold RJ, Kim HJ, Ishizuka J, et al.: A human gastric cancer cell line possesses a functional receptor for gastrin-releasing peptide. Cancer Invest 1998, 16:12-17.
64. Williams BY, Schonbrunn A: Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Cancer Res 1994, 54:818-824.
65. Carroll RE, Ostrovskiy D, Lee S, et al.: Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol 2000, 58:601-607.
66. Chave HS, Gough AC, Palmer K, et al.: Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer 2000, 82:124-130.
67. Carroll RE, Malkowskyj KA, Chakrabarti S, et al.: Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol 1999, 276:G655-G665.
68. Cassano G, Resta N, Gasparre G, et al.: The proliferative response of HT-29 human colon adenocarcinoma cells Io bombesin-like peptides. Cancer Lett 2001, 172:151-157.
69. Saurin JC, Rouault JP, Abello J, et al.: High gastrin releasing peptide receptor mRNA level is related to tumor dedifferentiation and lymphatic vessel invasion in human colon cancer. Eur J Cancer 1999, 35:125-132.
70. Saurin JC, Nemoz-Gaillard E, Sordat B, et al.: Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line. Cancer Res 1999, 59:962-967.
71. Preston SR, Woodhouse LF, Jones-Blackett S1 et al.: High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. Br J Cancer 1995, 71:1087-1089.
72. Radulovic SS, Milovanovic SR, Cai RZ, et al.: The binding of bombesin and somatostatin and their analogs to human colon cancers. Proc Soc Exp Biol Med 1992, 200:394-401.
73. Frucht H, Gazdar AF, Park JA, et al.: Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992, 52:1114-1122.
74. Bologna M, Festuccia C, Muzi P, et al.: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989, 63:1714-1720.
75. Burghardt B, Wenger C, Barabas K, et al.: GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF. Peptides 2001, 22:1119-1128.
76. Ishimaru H, Kageyama Y, Hayashi T, et al.: Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases. Acta Oncol 2002, 41:289-296.
77. Sun B, Halmos G, Schally AV, et al.: Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 2000, 42:295-303.
78. Bartholdi MF, Wu JM, Pu H, et al.: In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. Int J Cancer 1998, 79:82-90.
79. Markwalder R, Reubi JC: Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 1999, 59:1152-1159.
80. Pansky A, De Weerth A, Fasler-Kan E, et al.: Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma. J Am Soc Nephrol 2000, 11:1409-1418.
81. Kim S, Hu W, Kelly DR, et al.: Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 2002, 235:621-629; discussion 629-630.
82. Sebesta JA, Young A, Bullock J, et al.: Gastrin-releasing peptide: a potential growth factor expressed in human neuroblastoma tumors(1). Curr Surg 2001, 58:86-89.
83. Charitopoulos KN, Lazaris AC, Aroni K, et al.: Immunodetection of gastrin-releasing peptide in malignant melanoma cells. Melanoma Res 2000, 10:395-400.
84. Pansky A, Peng F, Eberhard M, et al.: Identification of functional GRP-preferring bombesin receptors on human melanoma cells. Eur J Clin Invest 1997, 27:69-76.
85. Lawlor ER, Lim JF, Tao W, et al.: The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide. Cancer Res 1998, 58:2469-2476.
86. Sun B, Schally AV, Halmos G: The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul Pept 2000, 90:77-84.
87. Chalzistamou I, Schally AV, Sunday B, et al.: Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists. Br J Cancer 2000, 83:906-913.
88. Moody TW, Mahmoud S, Staley J, et al.: Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. J Mol Neurosci 1989, 1:235-242.
89. Moody TW, Pert CB, Gazdar AF, et al.: High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 1981, 214:1246-1248.
90. Hamid QA, Corrin B, Dewar A, et al.: Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung. J Pathol 1990, 161:145-151.
91. Nowicki M, Miskowiak B: Comparison of the cell immunophenotype of metastatic and primary foci in stage IV-S neuroblastoma. Folia Histochem Cytobiol 2002, 40:297-303.
92. Battey JF, Way JM, Corjay MH, et al.: Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci U S A 1991, 88:395-399.
93. Spindel ER, Giladi E, Brehrn P, et al.: Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol Endocrinol 1990, 4:1956-1963.
94. Giladi E, Nagalla SR, Spindel ER: Molecular cloning and characterization of receptors for the mammalian bombesin-like peptides. J Mol Neurosci 1993, 4:41-54.
95. Weber HC, Jensen RT, Battey JF: Molecular organization of the mouse gastrin-releasing peptide receptor gene and its promoter. Gene 2000, 244:137-149.
96. Lin Y, Jian X, Lin Z, et al.: Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation. J Pharmacol Exp Ther 2000, 294:1053-1062.
97. Tokita K, Hocart SJ, Coy DH, et al.: Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. Mol Pharmacol 2002, 61:1435-1443.
98. Benya RV, Fathi Z, Battey JF, et al.: Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. J Biol Chem 1993, 268:20285-20290.
99. Benya RV, Kusui T, Katsuno T, et al.: Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. Mol Pharmacol 2000, 58:1490-1501.
100. Corjay MH, Dobrzanski DJ, Way JM, et al.: Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 1991, 266:18771-18779.
101. Von Schrenck T, Heinz-Erian P, Moran T, et al.: Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol 1989, 256:G747-G758.
102. Wada E, Way J, Shapira H, et al.: cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 1991, 6:421-430.
103. Fathi Z, Corjay MH, Shapira H, et al.: BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem 1993, 268:5979-5984.
104. Gorbulev V, Akhundova A, Buchner H, et al.: Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur J Biochem 1992, 208:405-410.
105. Gorbulev V, Akhundova A, Grzeschik KH, et al.: Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus. FEBS Lett 1994, 340:260-264.
106. Ohki-Hamazaki H, Wada E, Matsui K, et al.: Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse. Brain Res 1997, 762:165-172.
107. Weber HC, Hampton LL, Jensen RT, et al.: Structure and chromosomal localization of the mouse bombesin receptor subtype 3 gene. Gene 1998, 211:125-131.
108. Carney DN, Moody T, Cuttitta F: Bombesin: a potent mitogen for small cell lung cancer. Ann N Y Acad Sci 1988, 547:303-309.
109. Weber S, Zuckerman JE, Bostwick DG, et al.: Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest 1985, 75:306-309.
110. Yano T, Pinski J, Groot K, et al.: Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992, 52:4545-4547.
111. Murphy LO, Cluck MW, Lovas S, et al.: Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. Br J Cancer 2001, 84:926-935.
112. Bold RJ, Lowry PS, Ishizuka J, et al.: Bombesin stimulates the in vitro growth of a human gastric cancer cell line. J Cell Physiol 1994, 161:519-525.
113. Sharif TR, Luo W, Sharif M: Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Mol Cell Endocrinol 1997, 130:119-130.
114. Kiaris H, Schally AV, Sunday B, et al.: Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide. Oncogene 1999, 18:7168-7173.
115. Carroll RE, Matkowskyj KA, Tretiakova MS, et al.: Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer. Cell Growth Differ 2000, 11:385-393.
116. Qu X, Xiao D, Weber H: Human gastrin-releasing peptide receptor mediates sustained CREB phosphorylation and transactivation in HuTu 80 duodenal cancer cells. FEBS Lett 2002, 527:109. Gastrin-releasing peptide receptor activation stimulated sustained CREB phosphorylation and transactivation in duodenal cancer cells through a PKC-dependent and partially p38 MAPK-dependent pathway. This novel signaling mechanism may be of importance for regulation of CREB-dependent gene expression in human cancers expressing functional GRP-R.
117. Guo YS, Hellmich MR, Wen XD, et al.: Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 2001, 276:22941-22947.
118. Guo YS, Cheng JZ, Jin GF, et al.: Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways: evidence for involvement of ERK5 kinase and transactivation of EGF receptor. J Biol Chem 2002, 17:17.
119. Kim HJ, Evers BM, Guo Y, et al.: Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA). Surgery 1996, 120:130-136; discussion 136-137.
120. Kim HJ, Evers BM, Litvak DA, et al.: Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA. Am J Physiol Cell Physiol 2000, 279:C326-C334.
121. Rozengurt E: Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol Metab 2002, 13:128-134.
122. Wang JL, Kalyanaraman S. Vivo MD, et al.: Bombesin and thrombin affect discrete pools of intracellular calcium through different G-proteins. Biochem J 1996, 320:87-91.
123. 2+ influx in bombesin-induced mitogenesis in Swiss 3T3 fibroblasts. J Biol Chem 1991, 266:1403-1409.
124. Fathi Z, Way JW, Corjay MH, et al.: Bombesin receptor structure and expression in human lung carcinoma cell lines. J Cell Biochem Suppl 1996, 24:237-246.
125. 2+ efflux in human breast cancer cells by bombesin. Cancer Res 1990, 50:235-239.
126. Wasilenko WJ, Cooper J, Palad AJ, et al.: Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate 1997, 30:167-173.
127. Aprikian AG, Han K, Chevalier S, et al.: Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J Mol Endocrinol 1996, 16:297-306.
128. Erusalimsky JD, Friedberg I, Rozengurt E: Bombesin, diacylglycerols, and phorbol esters rapidly stimulate the phosphorylation of an Mr = 80,000 protein kinase C substrate in permeabilized 3T3 cells: effect of guanine nucleotides. J Biol Chem 1988, 263:19188-19194.
129. Isacke CM, Meisenhelder J, Brown KD, et al.: Early phosphorylation events following the treatment of Swiss 3T3 cells with bombesin and the mammalian bombesin-related peptide, gastrin-releasing peptide. EMBO J 1986, 5:2889-2898.
130. Sbrissa D, Yamada H, Hajra A, et al.: Bombesin-stimulated ceramide production and MAP kinase activation in rabbit rectosigmoid smooth muscle cells. Am J Physiol 1997, 272:G1615-G1625.
131. Rey O, Young SH, Cantrell D, et al.: Rapid protein kinase D translocation in response to G protein-coupled receptor activation: dependence on protein kinase C. J Biol Chem 2001, 276:32616-32626.
132. Mehmet H, Morris C, Rozengurt E: Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP. Cell Growth Differ 1990, 1:293-298.
133. Seufferlein T, Withers DJ, Rozengurt E: Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin. J Biol Chem 1996, 271:21471-21477.
134. Pang L, Decker SJ, Saltiel AR: Bombesin and epidermal growth factor stimulate the mitogen-activated protein kinase through different pathways in Swiss 3T3 cells. Biochem J 1993, 289:283-287.
135. Charlesworth A, Rozengurt E: Bombesin and neuromedin B stimulate the activation of p42(mapk) and p74(raf-1) via a protein kinase C-independent pathway in Rat-1 cells. Oncogene 1997, 14:2323-2329.
136. Fiorucci S, Bufalari A, Distrutli E, et al.: Bombesin-induced pancreatic regeneration in pigs is mediated by p46Shc/p52Shc and p42/p44 mitogen-activated protein kinase upregulation. Scand J Gastroenterol 1998, 33:1310-1320.
137. Luttrell LM, Daaka Y, Delia Rocca GJ, et al.: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1 a fibroblasts: She phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem 1997, 272:31648-31656.
138. Koh SW, Leyton J, Moody TW: Bombesin activates MAP kinase in non-small cell lung cancer cells. Peptides 1999, 20:121-126.
139. Kiehne K, Herzig KH, Folsch UR: Differential activation of p42ERK2 and p125FAK by cholecystokinin and bombesin in the secretion and proliferation of the pancreatic amphicrine cell line AR42J. Pancreatology 2002, 2:46-53.
140. Douziech N, Calvo E, Laine J, et al.: Activation of MAP kinases in growth responsive pancreatic cancer cells. Cell Signal 1999, 11:591-602.
141. Prenzel N, Zwick E, Daub H, et al.: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
142. Santiskulvong C, Sinnett-Smith J, Rozengurt E: EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. Am J Physiol Cell Physiol 2001, 281:C886-C898.
143. Zachary I, Sinnett-Smith JW, Rozengurt E: Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells, I: activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 1986, 102:2211-2222.
144. Van Y, Shirakabe K, Werb Z: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 2002, 158:221-226. This elegant article for the first time elucidates how metalloprotease-mediated shedding regulates signaling pathways and provides novel insights on EGFR transactivation mediated by G-protein-coupled receptors. It determines that ADAM 10(KUZ) is involved in GPCR-mediated Ras and Erk activation via EGFR transactivation.
145. Carpenter G: EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Sci STKE 2000, 2000:E1.
146. Leopoldt D, Yee HF Jr, Saab S, et al.: Tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin does not require extracellular signal-regulated kinase activation in Swiss 3T3 cells stimulated by bombesin or platelet-derived growth factor. J Cell Physiol 2000, 183:208-220.
147. Charlesworth A, Broad S, Rozengurt E: The bombesin/GRP receptor transfected into Rat-1 fibroblasts couples to phospholipase C activation, tyrosine phosphorylation of p125FAK and paxillin and cell proliferation. Oncogene 1996, 12:1337-1345.
148. Leyton J, Garcia-Marin LJ, Tapia JA, et al.: Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells. Cancer Lett 2001, 162:87-95.
149. Tallett A, Chilvers ER, MacKinnon AC, et al.: Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines. Peptides 1996, 17:665-673.
150. Aprikian AG, Tremblay L, Man K, et al.: Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int J Cancer 1997, 72:498-504.
151. Duncan MD, Harmon JW, Duncan LK: Actin disruption inhibits bombesin stimulation of focal adhesion kinase (pp125FAK) in prostate carcinoma. J Surg Res 1996, 63:359-363.
152. Rinn HM, Ridley AJ: Rho stimulates tyrosine phosphorylation of focal adhesion kinase, p130 and paxillin. J Cell Sci 1996, 109:1133-1141.
153. Barry ST, Critchley DR: The RhoA-dependent assembly of focal adhesions in Swiss 3T3 cells is associated with increased tyrosine phosphorylation and the recruitment of both ppl 25FAK and protein kinase C-delta to focal adhesions. J Cell Sci 1994, 107:2033-2045.
154. Sinnett-Smith J, Santiskulvong C, Duque J, et al.: [D-Arg(1),D-Trp(5,7, 9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells. J Biol Chem 2000, 275:30644-30652.
155. Needham LK, Rozengurt E: Galpha12 and GalphalS stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin, and pi 30 Crk-associated substrate. J Biol Chem 1998, 273:14626-14632.
156. Rankin S, Morii N, Narumiya S, et al.: Botulinum C3 exoenzyme blocks the tyrosine phosphorylation of pi 25FAK and paxillin induced by bombesin and endothelin. FEBS Lett 1994, 354:315-319.
157. 2+ mobilization, and the actin cytoskeleton. J Biol Chem 1993, 268:14261-14268.
158. Lee LF, Guan J, Qiu Y, et al.: Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 2001, 21:8385-8397.
159. Rankin S, Hooshmand-Rad R, Claesson-Welsh L, et al.: Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J Biol Chem 1996, 271:7829-7834.
160. Rodriguez-Fernandez JL, Rozengurt E: Bombesin, bradykinin, vasopressin, and phorbol esters rapidly and transiently activate Src family tyrosine kinases in Swiss 3T3 cells: dissociation from tyrosine phosphorylation of pi 25 focal adhesion kinase. J Biol Chem 1996, 271:27895-27901.
161. Zhukova E, Sinnett-Smith J, Rozengurt E: Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J Biol Chem 2001, 276:40298-40305.
162. Paolucci L, Rozengurt E: Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Res 1999, 59:572-577.
163. Rey O, Sinnett-Smith J, Zhukova E, et al.: Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J Biol Chem 2001, 276:49228-49235.
164. Yuan J, Slice LW, Rozengurt E: Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. J Biol Chem 2001, 276:38619-38627.
165. Yuan J, Slice L, Walsh JH, et al.: Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q). J Biol Chem 2000, 275:2157-2164.
166. Draoui M, Chung P, Park M, et al.: Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides 1995, 16:289-292.
167. Xiao D, Qu X, Weber HC: GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells. Regul Pept 2002, 109:141-148.
168. Mehmet H, Millar JB, Lehmann W, et al.: Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: the role of prostaglandin E2-mediated cyclic AMP accumulation. Exp Cell Res 1990, 190:265-270.
169. Mehmet H, Littlewood TD, Sinnett-Smith J, et al.: Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts. Cell Growth Differ 1997, 8:187-193.
170. Cuttitta F, Carney DN, Mulshine J, et al.: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985, 316:823-826.
171. Mahmoud S, Staley J, Taylor J, et al.: [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res 1991, 51:1798-1802.
172. Chaudhry A, Carrasquillo JA, Avis IL, et al.: Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res 1999, 5:3385-3393.
173. Lango MN, Dyer KF, Lui VW, et al.: Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 2002, 94:375-383.
174. Langer DA, Kautzman D1 Kane MA: Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor. Lung Cancer 2002, 36:235-242.
175. Gollan TJ, Green MR: Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. J Virol 2002, 76:3564-3569. This report provides a novel strategy to target selectively human cancer cells expressing functional GRP-R by modifying a retroviral envelope protein with short GRP peptides. Pseudotype vims transduces successfully target cells with cognate GRP-R and causes cell death via delivery of thymidine kinase activity in the presence of ganciclovir.
176. De Vincentis G, Scopinaro F, Varvarigou A, et al.: Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery? Tumori 2002, 88:S28-S30. This article and [177] are two very small, preliminary studies on the tumor localization in vivo using a radiolabeled 99mTechnecium-bombesin compound and scintigraphy.
177. Scopinaro F, Varvarigou A, Ussof W, et al.: Breast cancer takes up 99mTc bombesin: a preliminary report. Tumori 2002, 88:S25-S28. See [176].